Status:
RECRUITING
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Lead Sponsor:
PROspective Renal Cancer Cohort Foundation
Collaborating Sponsors:
Comprehensive Cancer Centre The Netherlands
Merck Sharp & Dohme LLC
Conditions:
Renal Cancer
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
PRO-RCC is a nationwide long-term cohort for the collection of real-world clinical data, patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) that provides an inf...
Detailed Description
PRO-RCC is designed as a multicenter cohort for all Dutch patients with localized RCC or metastatic renal cell carcinoma (mRCC). The clinical data collection is embedded in the framework of the Nether...
Eligibility Criteria
Inclusion
- newly diagnosed patients with RCC or synchronous metastatic RCC
- metachronous metastasized RCC
- age \>18 years
- capable of understanding Dutch language
Exclusion
- n/a
Key Trial Info
Start Date :
January 19 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05326620
Start Date
January 19 2023
End Date
January 1 2030
Last Update
June 6 2025
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC locatie VUMC
Amsterdam, North Holland, Netherlands
2
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands
3
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands
4
Meander Medisch Centrum
Amersfoort, Netherlands